期刊
BIOMEDICINES
卷 11, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11061632
关键词
epilepsy; history; antiepileptic drugs; artificial intelligence; drug development
This article provides a comprehensive narrative review of the history of antiepileptic drugs (AEDs) and their development over time. It explores the role of serendipity in the discovery of essential AEDs and delves into the progression of preclinical models used in AED development. The article also provides an overview of the clinical advancement of major AEDs and discusses the contributions of artificial intelligence.
This article provides a comprehensive narrative review of the history of antiepileptic drugs (AEDs) and their development over time. Firstly, it explores the significant role of serendipity in the discovery of essential AEDs that continue to be used today, such as phenobarbital and valproic acid. Subsequently, it delves into the historical progression of crucial preclinical models employed in the development of novel AEDs, including the maximal electroshock stimulation test, pentylenetetrazol-induced test, kindling models, and other animal models. Moving forward, a concise overview of the clinical advancement of major AEDs is provided, highlighting the initial milestones and the subsequent refinement of this process in recent decades, in line with the emergence of evidence-based medicine and the implementation of increasingly rigorous controlled clinical trials. Lastly, the article explores the contributions of artificial intelligence, while also offering recommendations and discussing future perspectives for the development of new AEDs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据